DB-007-4

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameDB-007-4
Drug Alias NameDB-007-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-17 inhibitors
TargetsInterleukin-17
Therapy Area/IndicationsDermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDerm-Biome Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesDerm-Biome Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDermatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A